356 related articles for article (PubMed ID: 34817726)
1. The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.
Leys F; Wenning GK; Fanciulli A
Neurol Sci; 2022 Jan; 43(1):187-198. PubMed ID: 34817726
[TBL] [Abstract][Full Text] [Related]
2. An overview on pure autonomic failure.
Pavy-Le Traon A; Foubert-Samier A; Fabbri M
Rev Neurol (Paris); 2024; 180(1-2):94-100. PubMed ID: 38129276
[TBL] [Abstract][Full Text] [Related]
3. Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.
Gibbons CH; Levine T; Adler C; Bellaire B; Wang N; Stohl J; Agarwal P; Aldridge GM; Barboi A; Evidente VGH; Galasko D; Geschwind MD; Gonzalez-Duarte A; Gil R; Gudesblatt M; Isaacson SH; Kaufmann H; Khemani P; Kumar R; Lamotte G; Liu AJ; McFarland NR; Miglis M; Reynolds A; Sahagian GA; Saint-Hillaire MH; Schwartzbard JB; Singer W; Soileau MJ; Vernino S; Yerstein O; Freeman R
JAMA; 2024 Apr; 331(15):1298-1306. PubMed ID: 38506839
[TBL] [Abstract][Full Text] [Related]
4. Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.
Goldstein DS; Isonaka R; Lamotte G; Kaufmann H
Clin Auton Res; 2021 Dec; 31(6):677-684. PubMed ID: 34669076
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies - a mini review.
Singer W
Clin Auton Res; 2022 Aug; 32(4):291-297. PubMed ID: 35895157
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
[TBL] [Abstract][Full Text] [Related]
7. Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies.
Palermo G; Del Prete E; Bonuccelli U; Ceravolo R
J Neurol; 2020 Dec; 267(12):3444-3456. PubMed ID: 32594302
[TBL] [Abstract][Full Text] [Related]
8. Autonomic Dysfunction in α-Synucleinopathies.
Mendoza-Velásquez JJ; Flores-Vázquez JF; Barrón-Velázquez E; Sosa-Ortiz AL; Illigens BW; Siepmann T
Front Neurol; 2019; 10():363. PubMed ID: 31031694
[TBL] [Abstract][Full Text] [Related]
9. Neuropathology and molecular diagnosis of Synucleinopathies.
Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
[TBL] [Abstract][Full Text] [Related]
10. Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
Singer W; Berini SE; Sandroni P; Fealey RD; Coon EA; Suarez MD; Benarroch EE; Low PA
Neurology; 2017 Mar; 88(12):1129-1136. PubMed ID: 28202694
[TBL] [Abstract][Full Text] [Related]
11. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.
Rossi M; Candelise N; Baiardi S; Capellari S; Giannini G; Orrù CD; Antelmi E; Mammana A; Hughson AG; Calandra-Buonaura G; Ladogana A; Plazzi G; Cortelli P; Caughey B; Parchi P
Acta Neuropathol; 2020 Jul; 140(1):49-62. PubMed ID: 32342188
[TBL] [Abstract][Full Text] [Related]
12. Predicting phenoconversion in pure autonomic failure.
Coon EA; Mandrekar JN; Berini SE; Benarroch EE; Sandroni P; Low PA; Singer W
Neurology; 2020 Aug; 95(7):e889-e897. PubMed ID: 32546656
[TBL] [Abstract][Full Text] [Related]
13. Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.
Foulds PG; Yokota O; Thurston A; Davidson Y; Ahmed Z; Holton J; Thompson JC; Akiyama H; Arai T; Hasegawa M; Gerhard A; Allsop D; Mann DM
Neurobiol Dis; 2012 Jan; 45(1):188-95. PubMed ID: 21856424
[TBL] [Abstract][Full Text] [Related]
14. Unveiling autonomic failure in synucleinopathies: Significance in diagnosis and treatment.
Clement G; Cavillon G; Vuillier F; Bouhaddi M; Béreau M
Rev Neurol (Paris); 2024; 180(1-2):79-93. PubMed ID: 38216420
[TBL] [Abstract][Full Text] [Related]
15. Serotonin in synucleinopathies.
Hsam O; Kohl Z
Behav Brain Res; 2023 May; 445():114367. PubMed ID: 36863462
[TBL] [Abstract][Full Text] [Related]
16. Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy.
Kao AW; Racine CA; Quitania LC; Kramer JH; Christine CW; Miller BL
Alzheimer Dis Assoc Disord; 2009; 23(4):365-70. PubMed ID: 19935145
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing multiple system atrophy at the prodromal stage.
Xia C; Postuma RB
Clin Auton Res; 2020 Jun; 30(3):197-205. PubMed ID: 32232688
[TBL] [Abstract][Full Text] [Related]
18. 'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies?
Udow SJ; Robertson AD; MacIntosh BJ; Espay AJ; Rowe JB; Lang AE; Masellis M
J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1311-1321. PubMed ID: 27613160
[TBL] [Abstract][Full Text] [Related]
19. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
[TBL] [Abstract][Full Text] [Related]
20. Pure Autonomic Failure.
Thaisetthawatkul P
Curr Neurol Neurosci Rep; 2016 Aug; 16(8):74. PubMed ID: 27338613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
